3-(2,4-dimethoxybenzylidene)anabaseine has been researched along with a-582941 in 1 studies
| Studies (3-(2,4-dimethoxybenzylidene)anabaseine) | Trials (3-(2,4-dimethoxybenzylidene)anabaseine) | Recent Studies (post-2010) (3-(2,4-dimethoxybenzylidene)anabaseine) | Studies (a-582941) | Trials (a-582941) | Recent Studies (post-2010) (a-582941) |
|---|---|---|---|---|---|
| 166 | 8 | 81 | 18 | 0 | 8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arias, HR; Kos, T; Nikiforuk, A; Popik, P; Potasiewicz, A; Puia, G; Ravazzini, F | 1 |
1 other study(ies) available for 3-(2,4-dimethoxybenzylidene)anabaseine and a-582941
| Article | Year |
|---|---|
Pro-cognitive activity in rats of 3-furan-2-yl-N-p-tolyl-acrylamide, a positive allosteric modulator of the α7 nicotinic acetylcholine receptor.
Topics: Acrylamides; Allosteric Regulation; alpha7 Nicotinic Acetylcholine Receptor; Animals; Benzylidene Compounds; Cell Line, Tumor; Cognition; Furans; Humans; Male; Nicotinic Agonists; Pyridazines; Pyridines; Pyrroles; Rats; Rats, Sprague-Dawley; Scopolamine | 2015 |